The last thing I should do is comment on share price but I saw some sales at $1.45 this morning.

Now that the FDA has approved apabetalone for BETonMACE then if new financing comes in in some exceptable form and if the futility analysis passes the signs are looking good. Will these factors attract new demand and drive the share price back up? Will BP start to think seriously about about apabetalone?(no evidence over the past few years)

If Don has been working on a partnership deal similar to Hepalink and if it is contingent on FA passing then a new deal could change and enhance the complexion of this business in a significant manner e.g. if it is a geographic rights deal.

Will FDA approval spir more independent academic research on apabetalone?

If BoM passes FA there is still 18 months until the end of the trial. Lots of time for investors to sit on the sidelines.

If FA passes in terms of safety but the efficacy impact is minimal it would seem to me that someone needs to make a decision as to whether to continue investing in the trial but how does management do this if they do not know the stats?

Just some thoughts rambling in my head. GLTA

Toinv